Sarepta Therapeutics Inc. News
The Sarepta Therapeutics Pipeline No One is Talking About
Gene therapy and gene editing get all the glory, but investors shouldn't overlook an emerging group of tools.
Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted
The share price dipped below $1 -- into penny stock territory -- but analysts are optimistic they'll recover.
Barclays Lists Halliburton, Dick's, Ally as 2022 Earnings Winners
Barclays made a list of 35 stocks with overweight ratings that it expects to benefit from strong earnings next year.
Sarepta Higher After Progress With Muscular Dystrophy Drug Trial
Sarepta's trial supports its drug's 'potentially differentiated profile' to treat Duchenne muscular dystrophy, the company said. The stock is higher.
Boeing, Micron, Pfizer, Sarepta - Friday's Premarket Movers
Stocks moving in premarket trading Friday include Boeing, Micron, Pfizer, Sarepta and Moderna.
Sarepta Sinks on Disappointing Gene-Therapy Study Results
Sarepta shares lose half their value after a gene-therapy study seen as a shoo-in treatment for Duchenne muscular dystrophy produces disappointing results.
Headlight Stocks: Cramer's 'Mad Money' Recap (Wednesday 8/5/20)
Cramer says buyers are betting science will beat the virus. Here are the companies that can light the way forward.
Boeing, 'Rise of Skywalker,' Sarepta, Dow Futures, Trade Optimism - 5 Things You Must Know Monday
U.S. stocks are poised to again hit fresh record highs as optimism rises around the 'phase one' trade agreement between the United States and China; Boeing's Starliner returns to Earth; 'The Rise of Skywalker' makes $175.5 million at the weekend box office but still disappoints.
Sarepta Therapeutics Surges on FDA Approval of Muscular Dystrophy Treatment
Shares soar after the biotech company receives fast-track approval for its injectable treatment for Duchenne muscular dystrophy.
Sarepta Shares Rise on Positive Gene Therapy Trial Results
The nine-month results showed improvements for three clinical trial participants with Limb-girdle muscular dystrophy.
Breaking News
A New Take on the Big Mac (May Be) Headed to U.S. McDonald's Menus
This is very different than the Big Mac you know and love.
Crypto Evangelist Mark Cuban Is in Trouble
The billionaire and crypto investor was in business with Voyager Digital which went bankrupt early July.
We're Enduring 'Housing Recession,' Homebuilders' Economist Says
The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.
Elon Musk Pampers His Ties with China
China is a crucial country for Tesla for its domination of the market of electric vehicles.